GlassScriptPhysician profile
Didier Demesmin
NPI 1336170216
$32,892.45
in general payments reported to CMS, 2019-2025
34 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $347 · 2021: $2,421 · 2022: $1,780 · 2023: $17K · 2024: $8,397 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $7,104 · Travel and Lodging: $493 · Entertainment: $13.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,000.00 |
| Food and Beverage | $7,104.39 |
| Travel and Lodging | $492.76 |
| Entertainment | $13.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Milestone Scientific INC. | $20,000.00 | 2023-2024 | |
| Boston Scientific Corporation | $3,937.56 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Painteq LLC | $2,635.55 | 2021-2024 | Painteq |
| Medtronic, INC. | $982.15 | 2022-2025 | Venaseal, Intellis Adaptivestim |
| Nevro Corp. | $857.71 | 2019-2024 | Senza |
| Abbott Laboratories | $723.84 | 2019-2025 | Eterna, Proclaim |
| Biotronik Nro, INC. | $602.84 | 2024-2025 | Prospera |
| Saluda Medical Americas, INC. | $452.25 | 2023-2025 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $434.78 | 2022-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $336.92 | 2020-2025 | Sprint Pns System |
| Globus Medical, INC. | $250.26 | 2025 | Senza, Vyrsa V1 |
| Scilex Pharmaceuticals INC. | $216.32 | 2021 | |
| Si-Bone, INC. | $206.89 | 2024-2025 | |
| Stimwave Technologies Incorporated | $200.00 | 2019 | |
| Foundation Fusion Solutions, LLC | $160.30 | 2023-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $135.30 | 2024 | Mirragen Advanced Wound Matrix |
| Medtronic USA, INC. | $133.42 | 2019-2020 | |
| Nalu Medical, INC. | $126.04 | 2021 | |
| Captiva Spine INC | $94.10 | 2025 | Watchtower |
| Bioventus LLC | $70.83 | 2019-2025 | Gelsyn-3, Durolane |
| Electronic Waveform Lab, INC. | $56.60 | 2020-2023 | |
| Pacira Therapeutics, INC. | $55.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $52.31 | 2021 | |
| Relievant Medsystems, INC. | $32.59 | 2023 | Intracept |
| Inspire Medical Systems, INC. | $23.99 | 2023 | Inspire |
| Avanos Medical | $22.84 | 2023 | Genvisc 850 Sodium Hyaluronate |
| International Rehabilitative Sciences, INC | $20.61 | 2025 | Rs-4i Plus With Intersperse |
| Depuy Synthes Sales INC. | $19.02 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.99 | 2020 | |
| Integrity Implants INC. | $13.01 | 2021 | |
| Redhill Biopharma INC. | $12.52 | 2021 | |
| Vertiflex, INC. | $11.41 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Didier Demesmin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.